Skip to main content
. 2022 Jan 25;14(2):276. doi: 10.3390/pharmaceutics14020276

Table 3.

Process parameters evaluated for the inline sonication method scale-up.

Inline Sonication
Exp. No. API DP Solution DP Flowrate (mL/min) CP Solution CP Flowrate (mL/min) EP Solution EP Flowrate (mL/min) Throughput (g/h)
3 - 4.5 wt% PLGA, 85.9 wt% EtOAc, 9.6 wt% DMSO 2 2 wt% PVA 6 MilliQ water 60 5
4 - 8.3 wt% PLGA, 74.3 wt% EtOAc, 5.7 wt% DMSO 2 2 wt% PVA 6 MilliQ water 60 10
5 - 14.1 wt% PLGA, 56.2 wt% EtOAc, 29.7 wt% DMSO 2 2 wt% PVA 6 MilliQ water 60 19
6 - 14.1 wt% PLGA, 56.2 wt% EtOAc, 29.7 wt% DMSO 4 2 wt% PVA 12 MilliQ water 120 38
7 Placebo 14.1 wt% PLGA, 56.2 wt% EtOAc, 29.7% DMSO 8 2 wt% PVA 24 MilliQ water 240 76
8 Ritonavir 13.9 wt% PLGA, 55.4 wt% EtOAc, 1.5 wt% ritonavir, 29.2 wt% DMSO 8 2 wt% PVA 24 MilliQ water 240 84
9 Celecoxib 13.9 wt% PLGA, 55.4 wt% EtOAc, 1.5 wt% ritonavir, 29.2 wt% DMSO 8 2 wt% PVA 24 MilliQ water 240 84